Customer Service
About Us
Quality Control
Privacy Policy

Search:

For:



Back to Pure NewsCaps Home 06/01/2006


Featured Articles

-New Athletic Program: Products for Enhanced Endurance, Strength/Power and Post-Exercise Recovery…*

-Vitamin K: An Interview with Dr. Ralph Holsworth, D.O. and Dr. Mark Swanson, N.D.…*

Product Highlights

-Read more about our exciting offers for June

New Products

-May/June 2006 New Products

Featured Abstracts

-Healthy plasma levels of vitamin K promote gamma-carboxylation of osteocalcin, healthy bone mineralization and arterial health…*

-The combination of vitamins K and D helps maintain healthy calcium metabolism in vascular tissues and supports cardiovascular health…*

-Lycopene and other tomato cartenoids act as free radical scavengers and promote healthy systolic and diastolic cardiovascular function…*

-Methylsulfonylmethane (MSM) enhances joint comfort and function in the knee...*

-Boswellia promotes respiratory health, including vital capacity, expiratory volume and air flow rate…*

-Guggul (Commiphora mukul) supports healthy 5'-monodeiodinase enzyme activity and thyroid hormone concentration…*

Frequently Asked Questions

-Is there a difference between natural and synthetic CoQ10?

Quick Fact

A Note on Xylitol


Efficacy of methylsulfonylmethane (MSM) in osteoarthritis pain of the knee: a pilot clinical trial

OBJECTIVE: Osteoarthritis (OA) is the most common form of arthritis and the second most common cause of long-term disability among middle-aged and older adults in the United States. Methylsulfonylmethane (MSM) is a popular dietary supplement used as a single agent and in combination with other nutrients, and purported to be beneficial for arthritis. However, there is paucity of evidence to support the use of MSM. METHODS: A randomized, double-blind, placebo-controlled trial was conducted. Fifty men and women, 40-76 years of age with knee OA pain were enrolled in an outpatient medical center. Intervention was MSM 3g or placebo twice a day for 12 weeks (6g/day total). Outcomes included the Western Ontario and McMaster University Osteoarthritis Index visual analogue scale (WOMAC), patient and physician global assessments (disease status, response to therapy), and SF-36 (overall health-related quality of life). RESULTS: Compared to placebo, MSM produced significant decreases in WOMAC pain and physical function impairment (P<0.05). No notable changes were found in WOMAC stiffness and aggregated total symptoms scores. MSM also produced improvement in performing activities of daily living when compared to placebo on the SF-36 evaluation (P<0.05). CONCLUSION: MSM (3g twice a day) improved symptoms of pain and physical function during the short intervention without major adverse events. The benefits and safety of MSM in managing OA and long-term use cannot be confirmed from this pilot trial, but its potential clinical application is examined. Underlying mechanisms of action and need for further investigation of MSM are discussed. Kim LS, Axelrod LJ, Howard P, Buratovich N, Waters RF. Osteoarthritis Cartilage. 2006 Mar;14(3):286-94.

For educational purposes only. Consult your physician for any health problems.

*These statements have not been evaluated by the Food & Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.


home  |  disclaimer  |  privacy policy  |  contact us  |  about pure